Results 251 to 260 of about 9,385,080 (408)

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches

European Journal of Immunology, Volume 53, Issue 1, January 2023., 2023
B lineage cells have been identified as therapeutic targets in autoimmune diseases. In the current review article, we provide an overview of novel strategies to target B lineage cells in autoimmune diseases, with a focus on inflammatory rheumatic diseases.
Ana Merino‐Vico, Giulia Frazzei, Jan Piet van Hamburg, Sander W. Tas   +3 more
wiley   +1 more source

Cellular therapies in rheumatic and musculoskeletal diseases. [PDF]

J Transl Autoimmun
Franco-Fuquen P, Figueroa-Aguirre J, Martínez DA, Moreno-Cortes EF, Garcia-Robledo JE, Vargas-Cely F, Castro-Martínez DA, Almaini M, Castro JE.   +8 more
europepmc   +1 more source

Computer users at risk: Health disorders associated with prolonged computer use [PDF]

By keeping in view the ISO standards which emphasize the assessment of use of a product, this research aims to assess the prolonged use of computers and their effects on human health. The objective of this study was to investigate the association between
Abida Ellahi, Fouzia Akram, M. Shahid Khalil   +2 more
core  

‘That's what makes me better’: Investigating children and adolescents' experiences of pain communication with healthcare professionals in paediatric rheumatology

European Journal of Pain, Volume 27, Issue 1, Page 111-128, January 2023., 2023
Abstract Background Pain communication should be an integral part of clinical consultations, particularly in paediatric rheumatology where children and adolescents frequently present with chronic musculoskeletal pain. To date, literature exploring the nature of and extent to which pain communication occurs has focused on healthcare professionals as ...
Rebecca Rachael Lee, Danielle Mountain, Mark Connelly, Tonya M. Palermo, Sarah Peters, Lis Cordingley, Janet E. McDonagh   +6 more
wiley   +1 more source

Preventative and therapeutic potential of tocotrienols on musculoskeletal diseases in ageing. [PDF]

Front Pharmacol, 2023
Saud Gany SL, Chin KY, Tan JK, Aminuddin A, Makpol S.   +4 more
europepmc   +1 more source

Effect of Preexisting Musculoskeletal Diseases on the 1-Year Incidence of Fall-related Injuries [PDF]

, 2012
Won Kyung Lee, Kyoung Ae Kong, Hyesook Park   +2 more
openalex   +1 more source

Clinical implications of teleradiology in rheumatic and musculoskeletal diseases: improving rheumatic care. [PDF]

Rheumatol Int
Yemeshev Y, Nurmashev B, Zimba O, Kocyigit BF.   +3 more
europepmc   +1 more source

Role of nitric oxide in musculoskeletal system diseases (part II)

, 2004
А. И. Дубиков, A A Cherepovsky, L A Belogolovyli, E A Medved, С. В. Никулин   +4 more
openalex   +1 more source

Immunosuppression Adversely Affects TST but Not IGRAs in Patients with Psoriasis or Inflammatory Musculoskeletal Diseases [PDF]

, 2012
Esko Tavast, Tamara Tuuminen, Sari H. Pakkanen, Mari Eriksson, Anu Kantele, Asko Järvinen, Liana Pusa, Tarja Mälkönen, Ilkka Seppälä, Heikki Repo, Marjatta Lerisalo-Repo   +10 more
openalex   +1 more source

Topical Mupirocin Treatment Reduces Interferon and Myeloid Signatures in Cutaneous Lupus Erythematous Lesions Through Targeting of Staphylococcus Species

Arthritis &Rheumatology, EarlyView.
Objective Cutaneous lupus erythematosus (CLE) is an inflammatory skin manifestation of systemic lupus erythematosus. Type I interferons (IFNs) promote inflammatory responses and are elevated in CLE lesions. We recently reported that CLE lesions are frequently colonized with Staphylococcus aureus.
Lisa Abernathy‐Close, Joseph Mears, Allison C. Billi, Sirisha Sirobhushanam, Celine Berthier, Annie Lu, Zeran Zhang, Amy Hurst, Johann E. Gudjonsson, J. Michelle Kahlenberg   +9 more
wiley   +1 more source